Figure 2.
(A). The workflow of an iTRAQ-based phosphoproteomic profiling experiment in response to DCA treatment; (B). A typical SCX chromatograph of a combined iTRAQ-labeled mitochondrial sample using KCl salt elution gradient (0–350 mM). The dashed line denotes the salt gradient across the chromatograph.
